When utilizing ISRT for Hodgkin lymphoma, what volumetric expansions (ITV and PTV) are appropriate on top of the CTV that includes the original pre-systemic therapy disease?

Topics: Hematologic Malignancies • Radiation Oncology • Hematology

How would these expansions differ based on the anatomic site being treated?

Answer from: Radiation Oncologist at Academic Institution

First, it is important to realize that involved-site radiation therapy (ISRT) for Hodgkin lymphoma is not a formulaic approach to field design. It requires careful evaluation of pre-chemotherapy imaging, fusing these with post-chemotherapy planning CT scans for optimal target delineation, evaluating...

Comments

Radiation Oncologist at University Hospital Basel
This is an excellent approach, Prof. @Kelsey! Than...

Related Questions